Cargando…
Amniotic membrane mesenchymal stromal cell-derived secretome in the treatment of acute ischemic stroke: A case report
BACKGROUND: Stroke is the second and third leading cause of death and disability, respectively. To date, no definitive treatment can repair lost brain function. Recently, various preclinical studies have been reported on mesenchymal stromal cells (MSCs) and their derivatives and their potential as a...
Autores principales: | Lin, Fu-Hong, Yang, Yu-Xiao, Wang, Yu-Jun, Subbiah, Suresh Kumar, Wu, Xiao-Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601006/ https://www.ncbi.nlm.nih.gov/pubmed/37900223 http://dx.doi.org/10.12998/wjcc.v11.i27.6543 |
Ejemplares similares
-
Amniotic Fluid-Derived Mesenchymal Stem/Stromal Cell-Derived Secretome and Exosomes Improve Inflammation in Human Intestinal Subepithelial Myofibroblasts
por: Katifelis, Hector, et al.
Publicado: (2022) -
Stem cell secretome derived from human amniotic fluid affords neuroprotection in an ischemic model
por: Kingsbury, Chase, et al.
Publicado: (2021) -
Disclosing the molecular profile of the human amniotic mesenchymal stromal cell secretome by filter-aided sample preparation proteomic characterization
por: Muntiu, Alexandra, et al.
Publicado: (2023) -
Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective
por: Papait, Andrea, et al.
Publicado: (2022) -
A nanocomposite hydrogel delivery system for mesenchymal stromal cell secretome
por: Shoma Suresh, K., et al.
Publicado: (2020)